X

Stay Connected

Sign Up for Updates

network1.png

PPA strives to improve patient health, advance medical innovation and fuel economic growth.

LEARN MORE
network1.png

The PhRMA Foundation supports the research and career endeavors of scientists in drug discovery and development.

LEARN MORE
network1.png

Access Better Coverage educates consumers about the ABCs of health coverage and access to medicines.

LEARN MORE
network1.png

We Work For Health aims to increase awareness by uniting workers throughout the industry.

LEARN MORE
network1.png

Patent protection should always be considered by an inventor during the initial stages of their invention.

LEARN MORE
logo_white_MyOldMeds-New-1.png

Working to spread awareness and education about the importance of secure drug disposal.

LEARN MORE
LTAC_NEW21.png

Many Americans are struggling to afford their medicines and have important questions about their medicine costs. Let's Talk About Cost addresses these questions.

LEARN MORE
logo_white_LTAM.png

There are a lot of conversations in Washington about how to change Medicare Part D, but they aren't always focused on what seniors care about most: affordability and predictability.

LEARN MORE
 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Priscilla VanderVeer

Priscilla VanderVeer is Vice President, Public Affairs, and leads the development, execution and management of public affairs and communications strategies and activities for PhRMA’s key state, federal and international advocacy priorities. She has more than two decades of experience communicating important health care issues to a wide variety of audiences, including medical, health and patient advocates, policymakers, opinion-leaders and the public. She lives in Annapolis, Maryland with her husband, Ken and their two dogs: Bea Arthur, a tiny 5 lb. Maltese and Henry, a slightly larger-than-average Yorkshire Terrier.

Recent Posts

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    May 27, 2016
Threats to multiple myeloma progress – Progress in the fight against multiple myeloma has led to remarkable results, allowing 80 percent of newly diagnosed patients to live more than four years. Yet...   Read More

Nearly 4.5 million jobs and counting

By Priscilla VanderVeer  |    May 17, 2016
At PhRMA, we have the honor of highlighting the hope that America’s biopharmaceutical companies bring to patients in the form of innovative treatments and cures. But beyond the value that medicines...   Read More

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    May 6, 2016
Stopping opioid abuse – PhRMA and its members stand with patients, providers, law enforcement, policymakers and others in calling for and supporting national policies and action to address opioid...   Read More

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    April 29, 2016
Fact Check Friday – When it comes to communications between with payers, biopharmaceutical companies are often constrained in sharing safety and efficacy information about medicines in development.  ...   Read More

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    April 15, 2016
Competition works for pricing – Despite misleading claims to the contrary, a new report from IMS Institute for Healthcare Informatics found that net prices for brand medicines increased just 2.8...   Read More

Week in review: The latest from PhRMA

By Priscilla VanderVeer  |    April 8, 2016
11 years of PPA – This week, we celebrated the 11th anniversary of the Partnership for Prescription Assistance (PPA) by launching a mobile app.  The new app will offer a single point of access to...   Read More

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    April 1, 2016
Discriminatory effect of insurance plan structure – New research from Harvard’s Center for Health Law and Policy Innovation (CHLPI) shows evidence that some insurance plans are designed to discourage...   Read More

Week in review: The latest from PhRMA

By Priscilla VanderVeer  |    March 25, 2016
FDA quality metrics:  Building on our constructive ideas for improvements to the FDA’s recent proposal for a mandatory metrics program, we featured a guest blog post from Mairead Goetz, head of...   Read More

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    March 18, 2016
ICYMI: Policy solutions for innovative treatment: Last week at our 2016 Annual Meeting, our president and CEO Steve Ubl discussed his vision for the organization and outlined policy solutions for...   Read More

What “value” means to me

By Priscilla VanderVeer  |    March 17, 2016
It’s March, which means it is National Kidney Month. More than 661,000 Americans have kidney failure. Every day, approximately 13 people die waiting for a kidney transplant. I am lucky to not be one...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates

Trending Posts

Most Popular Posts

Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."